James Huang is Director of WINDTREE THERAPEUTICS INC . Currently has a direct ownership of 296,281 shares of WINT, which is worth approximately $91,847. The most recent transaction as insider was on Jun 07, 2022, when has been sold 5,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 296K
0% 3M change
0% 12M change
Total Value Held $91,847

James Huang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2022
BUY
Grant, award, or other acquisition
-
5,000 Added 1.66%
296,281 Common Stock
Oct 19 2021
BUY
Open market or private purchase
$95,000 $1.9 p/Share
50,000 Added 14.65%
291,281 Common Stock
Mar 31 2021
BUY
Open market or private purchase
$354,000 $2.36 p/Share
150,000 Added 46.73%
171,000 Common Stock
Oct 23 2020
BUY
Open market or private purchase
$6,670 $6.67 p/Share
1,000 Added 4.55%
21,000 Common Stock

Also insider at

TCRT
Alaunos Therapeutics, Inc. Healthcare
CASI
CASI Pharmaceuticals, Inc. Healthcare
JH

James Huang

Director
Rockville, MD

Track Institutional and Insider Activities on WINT

Follow WINDTREE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WINT shares.

Notify only if

Insider Trading

Get notified when an Windtree Therapeutics Inc insider buys or sells WINT shares.

Notify only if

News

Receive news related to WINDTREE THERAPEUTICS INC

Track Activities on WINT